Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

Key Features

  • Ventricular premature beats or PVCs are isolated beats typically originating from the outflow tract or His-Purkinje regions of ventricular tissue

  • In most patients, the presence of PVCs is a benign finding; however, they may trigger ventricular tachycardia or ventricular fibrillation, especially in patients with underlying heart disease

Clinical Findings

  • Patients may be asymptomatic or experience palpitations, dizziness or vague chest pain

  • Some patients feel the irregular beat

  • Symptoms can often be secondary to post-PVC augmentation of contractility or a post-PVC compensatory pause

  • Exercise generally abolishes premature beats in normal hearts, and the rhythm becomes regular

  • Wide QRS complexes, differing in morphology from normal beats and usually not preceded by a P wave

  • Fully compensatory pause (no change in PP interval) usually


  • Ambulatory ECG monitoring may reveal more frequent and complex ventricular premature beats than occur in a single routine ECG

  • An echocardiogram should be performed when Holter monitoring has documented more than 10,000 PVCs per day


  • If no associated cardiac disease is present and if the ectopic beats are asymptomatic, no therapy is indicated

  • Patients with mild symptoms or anxiety from palpitations can be reassured about the benign nature of this arrhythmia

  • If PVCs are frequent (bigeminal or trigeminal pattern) or multifocal, following should be excluded:

    • Electrolyte abnormalities

      • Hypokalemia

      • Hyperkalemia

      • Hypomagnesemia

    • Occult cardiac disease

      • Ischemic heart disease

      • LV dysfunction

  • Pharmacologic treatment is indicated only for patients who are symptomatic or in whom cardiomyopathy develops (thought to be due to high burden of PVCs [generally > 10% of daily heart beats])

  • β-Blockers or non-dihydropyridine calcium channel blockers are appropriate as first-line therapy

  • Class I and III antiarrhythmic agents

    • May be effective in reducing ventricular premature beats

    • Poorly tolerated

    • Can be proarrhythmic in up to 5% of patients

  • Catheter ablation is a well-established therapy for symptomatic individuals

    • Who do not respond to medication

    • Whose burden of ectopic beats has resulted in a cardiomyopathy

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.